Genetic studies in isolated bilateral clubfoot detected by prenatal ultrasound.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 28 9 2022
medline: 20 1 2023
entrez: 27 9 2022
Statut: ppublish

Résumé

To evaluate the contribution of genetic investigations in case of isolated bilateral clubfoot detected by routine prenatal ultrasound. Pathogenic Copy Number Variations is about 3.9% in fetuses with isolated clubfoot (uni- or bilateral). We hypothesize that this rate could be higher in a homogenous group of fetuses with bilateral clubfoot. This retrospective single-center study included all women referred to our fetal-medicine center between 2013 and 2020 after ultrasound detection of isolated bilateral clubfoot. Genetic counseling was offered in which the woman was offered an amniocentesis for CMA and targeted investigation for Prader-Willi Syndrome (PWS), Steinert's disease and Spinal Muscular Atrophy (SMA). 34 women were referred, 18 of them consented to undergo genetic studies by amniocentesis (18/34; 52.9%). Pathogenic copy number variations (CNVs) were found in 2/18 (11.1%) of cases. One of these CNVs was directly linked to the clubfoot pathology (a deletion in 5q31.1 containing PITX1 gene). Four fetuses (4/18, 22.2%) had variants of unknown significance (VUS). No PWS, SMA or Steinert's disease was found. No case diagnosed with isolated clubfoot prenatally had additional anomalies postnatally. In the case of bilateral isolated clubfoot detected at the antenatal ultrasound, invasive prenatal testing should be offered, and if accepted, a CMA should be done, as pathogenic variations were observed in up to 11.1% of women who got amniocentesis. The findings of this study do not support the systematic recommendation of molecular studies for PWS, SMA, Steinert's disease.

Identifiants

pubmed: 36167341
doi: 10.1080/14767058.2022.2128654
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10384-10387

Auteurs

Matthieu Dap (M)

Obstetrics and Fetal medicine Unit, CHRU of Nancy, Nancy, France.
Department of Fetopathology and Placental Pathology, CHRU of Nancy, Nancy, France.

Hélène Harter (H)

Obstetrics and Fetal medicine Unit, CHRU of Nancy, Nancy, France.

Laetitia Lambert (L)

Department of Medical Genetics, CHRU of Nancy, Nancy, France.

Estelle Perdriolle-Galet (E)

Obstetrics and Fetal medicine Unit, CHRU of Nancy, Nancy, France.

Céline Bonnet (C)

Department of Genetics, CHRU de Nancy, Vandoeuvre-lès-Nancy, Nancy, France.

Olivier Morel (O)

Obstetrics and Fetal medicine Unit, CHRU of Nancy, Nancy, France.
INSERM, Diagnostic and Interventional Adaptive Imaging, University of Lorraine, Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH